Skip to content
In English |
En español
Search
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -3 of 3
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
10/5/2007
 
First Published:
3/24/2003
1.
Phase II Pilot Study of Post-Operative Intrathecal Radioimmunotherapy, Reduced-Dose Craniospinal Radiotherapy With Intensity-Modulated Radiotherapy Boost, and Chemotherapy in Patients With Standard-Risk Medulloblastoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Active
3 and over
NCI
MSKCC-02088
NCT00058370
Last Modified:
8/16/2008
 
First Published:
3/2/2007
2.
Phase II Study of Intrathecal Iodine I 131 Monoclonal Antibody 3F8 in Patients With GD2-Expressing Central Nervous System or Leptomeningeal Neoplasms
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Biomarker/Laboratory analysis, Treatment
Active
Any age
Other
MSKCC-05122
NCT00445965
Last Modified:
3/19/2007
 
First Published:
3/16/2007
3.
Phase I Study of Iodine I 131 Monoclonal Antibody 3F8 and Bevacizumab in Patients With Relapsed or Refractory Neuroblastoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Active
1 and over
NCI
MSKCC-06072
NCT00450827, 06-072
Select All on One Page
NCI Home
|
Text-Only Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute